FDMT · ISSUER CIK 1650648
4D Molecular Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 4D Molecular Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $3.1M of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 9 of 9 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$3.1MInsider selling
−$3.1MNet open-market
Oct 20, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 202616:56 | Oct 16, 2026 | FDMT | Chief Legal Officer | S · Sell10b5-1 | $12.84 | −1,635 | 8,617 | -16% | −$21K | ||
| Oct 20, 202616:56 | Oct 16, 2026 | FDMT | Chief Legal Officer | M · Exercise10b5-1 | $4.14 | +1,635 | 10,252 | +19% | $7K | ||
| Oct 7, 202617:11 | Oct 5, 2026 | FDMT | See Remarks, Director | S · Sell10b5-1 | $12.92 | −58,333 | 709,153 | -8% | −$754K | ||
| Sep 22, 202618:43 | Sep 16, 2026 | FDMT | Chief Legal Officer | S · Sell10b5-1Late 6d | $13.65 | −1,635 | 8,617 | -16% | −$22K | ||
| Sep 22, 202618:43 | Sep 16, 2026 | FDMT | Chief Legal Officer | M · Exercise10b5-1Late 6d | $4.14 | +1,635 | 10,252 | +19% | $7K | ||
| Sep 16, 202617:13 | Sep 14, 2026 | FDMT | See Remarks, Director | S · Sell10b5-1 | $13.90 | −58,333 | 767,486 | -7% | −$811K | ||
| Sep 3, 202618:55 | Sep 1, 2026 | FDMT | Chief Legal Officer | S · Sell10b5-1 | $14.00 | −584 | 8,617 | -6% | −$8K | ||
| Sep 3, 202618:55 | Sep 1, 2026 | FDMT | Chief Legal Officer | M · Exercise10b5-1 | $6.49 | +584 | 9,201 | +7% | $4K | ||
| Aug 21, 202616:06 | Aug 19, 2026 | FDMT | See Remarks, Director | S · Sell10b5-1 | $15.75 | −69,076 | 825,819 | -8% | −$1.1M | ||
| Aug 21, 202616:06 | Aug 19, 2026 | FDMT | See Remarks, Director | M · Exercise10b5-1 | $4.14 | +50,000 | 894,895 | +6% | $207K | ||
| Aug 17, 202617:34 | Aug 17, 2026from Aug 13, 2026 | FDMT | Chief Legal Officer | S · Sell10b5-1 | $12.10 | −3,270 | 8,617 | -28% | −$40K | ||
| Aug 17, 202617:34 | Aug 17, 2026from Aug 13, 2026 | FDMT | Chief Legal Officer | M · Exercise10b5-1 | $4.14 | +3,270 | 10,252 | +47% | $14K | ||
| Aug 5, 202616:10 | Aug 4, 2026 | FDMT | See Remarks, Director | S · Sell10b5-1 | $10.23 | −26,842 | 844,895 | -3% | −$275K | ||
| Aug 4, 202616:45 | Aug 3, 2026 | FDMT | See Remarks, Director | S · Sell10b5-1 | $10.05 | −12,415 | 871,737 | -1% | −$125K |